Close

UPDATE: Amgen (AMGN) Receives Positive EMA CHMP Opinion on Repatha as Hypercholesterolaemia, Mixed Dyslipidaemia Treatment

May 22, 2015 7:02 AM EDT Send to a Friend
(Updated - May 22, 2015 7:06 AM EDT)

Amgen (NASDAQ: AMGN) PCSK9 gets positive opinion from EMA, according to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login